United States · FDA National Drug Code directory
DOCETAXEL
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 16729-267_1fbda3cb-1ba1-490d-e063-6294a90a6777
- Product NDC
- 16729-267
- Form
- INJECTION, SOLUTION, CONCENTRATE
- Composition / generic term
- docetaxel
- Labeler
- Accord Healthcare Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20130530
- Source listing expiry
- 20261231
Source-listed ingredients
- DOCETAXEL ANHYDROUS — 20 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, MULTI-DOSE in 1 CARTON (16729-267-63) / 1 mL in 1 VIAL, MULTI-DOSE · 16729-267-63
- 1 VIAL, MULTI-DOSE in 1 CARTON (16729-267-64) / 4 mL in 1 VIAL, MULTI-DOSE · 16729-267-64
- 1 VIAL, MULTI-DOSE in 1 CARTON (16729-267-65) / 8 mL in 1 VIAL, MULTI-DOSE · 16729-267-65
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →